Print Page | Sign In | Join Today
VABIO E-News December 16, 2015
Share |

Become a Member

VABIO E-News: December 16, 2015 Edition

Focus Around Virginia 
A Word from CEO Jeff Gallagher

Members and friends of Virginia Bio,

I loved the book “Don’t Sweat the Small Stuff.” But in bioscience innovation and commercialization, don’t diss the really small stuff. It’s called “Nano” - Nanoparticles, nanotubes, nanosurfaces. And it’s big.

What’s up with “Nano”? First of all, materials can have very different properties and function in unique ways when structured at the nanoscale. When particles are created with dimensions of about 1–100 nanometers (where the particles can be “seen” only with scanning electron and atomic force microscopes and the like) the materials’ properties change significantly from those at larger scales.

Quantum effects rule the behavior and properties of particles, and in this size range properties such as melting point, fluorescence, electrical conductivity, magnetic permeability, and chemical reactivity change as a function of the size of the particle. Nanoscale gold particles, for example, change significantly from those at larger scale, and that can be put to practical use: nanoscale gold particles selectively accumulate in tumors, where they can enable both precise imaging and targeted laser destruction of the tumor by means that avoid harming healthy cells.

Nanoscale materials have enormously larger surface areas than similar masses of larger-scale materials. A cubic centimeter solid has a surface area of 6 square centimeters. Fill that same volume with 1-nanometer-sized cubes—1021 of them, each with an area of 6 square nanometers, and their total surface area comes to 6,000 square meters - bigger than a football field.

For complete article click here.

Thank you to our Premium Partners



Gold Partners:

Silver Partners:


In this issue
focus around Virginia
VABIO Articles
VABIO Community News


VABIO Community News 

VABIO Events
Virginia Bio Calendar




Make Plans for San Francisco Now

 Building on prior years’ successes, Virginia Bio is expanding opportunities for members in San Francisco during the JP Morgan Healthcare Conference week, January 10-14. The University of Virginia Darden School of Business has partnered with Virginia Bio to bring you the Virginia Reception on Sunday, January 10. Darden School of Business has invited all of their relevant industry and investor alumni to attend the reception to learn about Virginia’s companies and the wide variety of innovations taking place here. The reception will be held in the renowned Velvet Room at the Clift Hotel, only two blocks from Union Square.

Click here to register to attend the reception. Also, members can click here to reserve complimentary 1:1 meeting space during the week.

For complete article click here.

CEL-SCI Granted European Patent on Multikine

CEL-SCI Corporation has been granted a European patent on Multikine (Leukocyte Interleukin, Injection), its investigational Phase 3 cancer immunotherapy. The patent, number EP 1 753 452 B, is entitled: A METHOD FOR ALTERING THE CD4/CD8 RATIO AND THE MONONUCLEAR CELLULAR INFILTRATE INTO A TUMOR.

For complete article click here.

FDA Approves AquAdvantage Salmon

AquaBounty Technologies, Inc., a biotechnology company focused on enhancing productivity in aquaculture, and a majority-owned subsidiary of Intrexon Corporation, received U.S. Food and Drug Administration (FDA) approval on New Animal Drug Application for the production, sale, and consumption of its AquAdvantage Salmon, an Atlantic salmon that has been genetically enhanced to reach market size in less time than conventional farmed Atlantic salmon.

For complete article click here.

HemoShear Therapeutics Names H. Thomas Watkins to Board of Directors

HemoShear Therapeutics, LLC, a privately held biotechnology company focused on discovering drugs for metabolic disorders, announced today the appointment of H. Thomas Watkins to its Board of Directors. Mr. Watkins is the former president and chief executive officer of Human Genome Sciences (HGS), and also served as the chairman of the Biotechnology Industry Organization.

For complete article click here.

George Mason University Spinoff Ceres Targets a Rapidly Expanding Market

As posted online for Washington Business Journal, getting a timely diagnosis for patients with Lyme disease is tricky. In 2013, Virginia even passed a law requiring doctors to inform patients just how unreliable current blood tests can be.

But executives at George Mason University spinoff Ceres Nanosciences Inc. say they're poised to change that with a highly sensitive urine test they've developed for diagnosing the increasingly common tick-borne illness. Earlier this month, results supporting the reliability of their Lyme disease test were published in the Journal of Translational Medicine.

For complete article click here.

Apply to Present at BIO CEO & Investor Conference

The annual BIO CEO & Investor Conference being held in New York City on February 8-9, 2016 is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because the mission is to support industry-wide success, a broad and unbiased view of investment opportunities is presented.

For complete article click here.

VA Bio Helps VCU’s School of Medicine Graduate Students Learn Critical Networking Skills

The Graduate Student Programming Board on the MCV Campus in conjunction with Career Services at VCU coordinated a Networking 101 event. Several dozen students in VCU’s School of Medicine attended the recent event that offered tips to meet and mingle with potential employers – and then a chance to practice what they’d learned with members of VA Bio.

For complete article
click here.

Titan Medical Inc. Signs a Manufacturing Agreement with Cadence Device, Inc.


Titan Medical Inc. signed an agreement with Cadence Device, Inc., a wholly-owned subsidiary of Cadence, Inc. Under the terms of the agreement, Cadence will develop, manufacture and manage the supply chain, sterilization and distribution for multi-articulating robotic instruments for use with Titan’s SPORT Surgical System.

For complete article click here.

Governor McAuliffe Will Introduce Budget to Include Tax Cuts and Credits and $2.43 Billion Bond Package

Governor Terry McAuliffe will propose key tax cuts and credits designed to bolster Virginia’s business climate and generate swift incentives for economic growth.

For complete article click here.

The Governor's Fiscal Year 2017-2018 budget will also include a $2.43 billion bond package to support key capital projects that will enhance Virginia’s technological research and economic development infrastructure.

For complete article click here.

VCU, HDL Alums Launch Firm to Fight Liver Disease

With a $3 million capital raise underway, a group of VCU alumni and Health Diagnostic Laboratory veterans have launched a startup to find cures for “the worst epidemic you’ve never heard of.”

That’s how Rebecca Caffrey describes the two increasingly prevalent liver diseases that her new company, the 8-month-old Sanyal Biotechnology, was developed to combat.

For complete article click here.

Grisham Authors The Tumor to Advance Focused Ultrasound

Bestselling author, John Grisham, has been a board member and steadfast supporter of Focused Ultrasound Foundation for years. He has now written a book about focused ultrasound called The Tumor – a fictional account portraying the potential impact of FUS to all of our futures. The book hopes to ignite widespread interest and raise funds to support the Foundation’s work.

For complete article click here.

Aperiomics and ResourcePath Create Biotech Strategic Partnership for Pathogen Testing Services
 Aperiomics and ResourcePath, have entered a strategic partnership that is expected to support significant and rapid growth for each of these Virginia-based biotech companies. In a mutually beneficial exchange, ResourcePath supplies next-generation sequencing services and Aperiomics provides complex data analysis and access to cutting edge bioinformatics technology.

For complete article click here.

Two U.Va. Findings in the Running for Year’s Biggest Scientific Breakthroughs
Science, one of the world’s most prestigious scientific journals, has selected 10 finalists for the year’s biggest scientific breakthrough, and the University of Virginia has taken two spots on the list.Rivanna Medical has begun selling its Accuro device to anesthesia providers as a result of a successful product launch at the annual meeting of the American Society of Anesthesiologists (ASA) in San Diego last week. The company is also continuing discussions with three potential corporate partners.

For complete article click here.

ImmunArray's New Lupus Rule-Out Test Broadening Availability
After presenting at the annual meeting of the American College of Rheumatology in San Francisco last month – its sixth presentation at international medical conferences in as many months – the developer of a new rule-out test for lupus is broadening the test’s availability throughout the United States.

For complete article click here.

Virginia Beach Plans to Attract More Biomedical Business
Virginia Beach recently launched an initiative to increase the biomedical and life science industries in the area.

VABeachBio, a program approved by the Virginia Beach Development Authority, includes an agreement with Tidewater Community College to create a Bio Accelerator in the college’s Regional Health Professions Center.

For complete article click here.

NIH Seeking Information on Precision Medicine Initiative Rollout
The National Institutes of Health (NIH) has issued a request for input on strategies for conducting baseline physical evaluations of program volunteers, as well as ways to best obtain biospecimens from these individuals as part of the Precision Medicine Initiative.

For complete article click here.

New Challenge Launches to Create Startups Around Promising Cancer-Related, Nanotechnology Inventions

The Center for Advancing Innovation (CAI) has launched the Nanotechnology Startup Challenge for Cancer (NSC2). This is the third in a series of startup challenges developed from the partnership between CAI and National Cancer Institute’s Technology Transfer Center following two award-winning competitions, the Breast Cancer Startup Challenge and the Neuro Startup Challenge.

For complete article click here.

Welcome New Member: In Silico Solutions
In Silico Solutions, headquartered in Fairfax, VA, is a bioinformatics services company that performs data analysis and software tool development for genome-wide research projects. The company started as a bioinformatics division within Tiger Team Consulting and spun off as a separate company in 2007. In Silico employs scientists and technicians with extensive experience in bioinformatics and biostatistics.

The company performs contract research and collaborate on grant funded research with academic, government, and commercial organizations located throughout the United States. Long term relationships with research institutions including MD Anderson Cancer Center, the National Institute of Health, Johns Hopkins Institute for Computational Medicine, and the University of California Santa Cruz Genome Bioinformatics Group have been developed.

For more information please visit their website.

Welcome New Member: TearSolutions
TearSolutions, LLC is developing a novel ocular tear generation therapy for 'dry eye' disease through phase II human clinical trials. The platform technology is centered on the tear protein 'lacritin' and the proprietary drug 'Lacripep', a first-in-class topical synthetic peptide treatment for dry eye that addresses cause.

For more information please visit their website.

Welcome New Member: Squire Patton Boggs
Squire Patton Boggs has been providing quality legal services for more than a century. Combining sound legal counsel with a deep knowledge of their clients’ businesses aids in resolving their legal challenges.

Squire Patton Boggs advises a diverse mix of clients, from Fortune 100 and FTSE 100 corporations to emerging companies and from individuals to local and national governments. In the private sector, a full range of legal advice is provided to implement practical strategies and resolve disputes. In the public sector, they counsel governments on privatization of whole industries and on establishment of regulatory systems under which new private businesses can compete.

As needed, cross-practice, cross-border and industry-specific support is provided to clients as required for success in today’s competitive markets.

For more information please visit their website.
VABIO Community News TO TOP

Richard Atkinson, President of Obetech, LLC and Affiliate Clinical Professor of Internal Medicine/Endocrinology at VCU was recently invited to lectures with the European Nutrition Conference in Berlin on "Yogurt and Weight Management: New Insights on the Evidence " and at the Southern Conference on Clinical Trials in Florianopolis, Brazil in November on "Current status of obesity and the need for a paradigm shift."

Ben Burruss, Associate Scientist/QA Auditor at Toxicology Regulatory Services, Inc. (TRS), last month became a Registered Quality Assurance Professional in Good Laboratory Practices (RQAP-GLP). This professional credential is awarded by the Society of Quality Assurance (SQA) and demonstrates proof of knowledge of EPA, FDA, and OECD GLP regulations/guidelines and their application as well as a commitment to a high quality standard in the QA industry.

The House Committee on Science, Space, and Technology, Subcommittee on Research and Technology recently held a hearing entitled “The Future of Biotechnology: Solutions for Energy, Agriculture, and Manufacturing.” The Hearing was Chaired by Chairwoman Barbara Comstock (R—VA). The hearing sought to explore how new and emerging biotechnologies can increase productivity and improve outcomes in the energy, agriculture, and manufacturing industries, and examined the strengths and weaknesses of the existing framework.

Jeff Kelly has joined Cadence, Inc. as Vice President and General Manager of its finished device and plastic injection molding division. Jeff joins the team with over fifteen years of experience in key leadership roles for other medical and life science companies. Most recently, Jeff led a team for Quest Diagnostics responsible for marketing and sales, business development, and international expansion.

“We are very excited to have Jeff join our team,” stated Alan Connor, CEO. “He brings a wealth of knowledge with him, and I am very confident that he will help accelerate growth in these new business areas for Cadence.”

President/CEO of The Greater Richmond Partnership, Inc., Barry Matherly, CEcD FM, has been elected Chairman of the International Economic Development Council (IEDC) Board of Directors. Matherly, who will begin his one-year term Jan. 1, 2016, was voted into the position during the IEDC Annual Conference in Anchorage, Alaska.

The Virginia Bioinformatics Institute has a new direction and a new name — the Biocomplexity Institute of Virginia Tech. The changes reflect the evolution of life science research at Virginia Tech and the university’s ability to continually innovate and refresh its land-grant mission. The institute’s evolving name and research direction embody the university’s efforts to create graduates capable of solving complex problems of a regional, national, and global scale, many of which have yet to be envisioned, according to Virginia Tech President Timothy D. Sands.


Event: Toast of the Town Holiday Party
Where: UVA Licensing and Ventures Group, Charlottesville, VA
When: Thursday, December, 17
Details: Celebrate all the accomplishments of 2015 with VA Bio, CBIC and U.Va. Licensing & Ventures Group at the annual Holiday Party! December 17 from 5:00-8:00 PM.
Registration: Click here to register.

Event: Virginia Reception in San Francisco
Where: Clift Hotel, Velvet Room, San Francisco, CA
When: Sunday, January 10, 5:00pm -7:00pm
Details: Join us at this inaugural Virginia Reception on the eve of JPMorgan Health Care week, gathering Darden’s extensive network of alumni in health care and biotech, and leaders of Virginia bioscience companies and translational research centers. Rekindle relationships, make important new contacts and help yourself with a great start to the industry's premier capital formation and strategic partnering event. Let's accelerate bioscience commercialization across Virginia and the world.
Registration: Click here to register.

JANUARY 11 - 13
Event: Member Meeting Space in San Francisco
Where: Handlery Union Square Hotel, San Francisco, CA
When: Monday, January 11 - Wednesday, January 13
Details: Virginia Bio Members click here to reserve your complimentary space for 1:1 meetings while in San Francisco.

JANUARY 11 - 13
Event: Biotech Showcase 2016
Where: Parc 55 - A Hilton Hotel, 55 Cyril Magnin St, San Francisco, CA
When: Monday, January 11 - Wednesday, January 13
Details: Virginia Bio Members get $200 off Biotech Showcase. Please contact Liz Kelly for the discount codes.

Event: RESI San Francisco 2016
Where: Marine's Memorial Club & Hotel, 609 Sutter St, San Francisco, CA
When: Tuesday, January 12, 7:00am - 8:00pm
Details: Virginia Bio Members get $100 off RESI. Please contact Liz Kelly for the discount codes.

Event: Virginia Bio Commercialization Luncheon - January 2015
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, January 14, 11:30am - 1:30pm
Details: Coming soon.
Sponsors: Greater Richmond Partnership, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

Event: Annual BIO CEO & Investor Conference
Where: The Waldorf Astoria New York, New York
When: February 8-9
Details: Virginia Bio members receive 20% discount for conference. Please contact Liz Kelly for the discount codes.

Event: Virginia Bio Commercialization Luncheon - February 2016
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, February 11, 11:30am - 1:30pm
Details: Coming soon.
Sponsors: Greater Richmond Partnership, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

Event: 2016 VABIO Biotech and Beer Legislative Reception
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, January 14, 11:30am - 1:30pm
Details: Join the lively conversation at Biotech and Beer and annual Legislative Reception. Mix and mingle with state officials, lend your voice to supporting our initiatives. Meet old friends and new colleagues in the life science community.Complimentary admission for all bioscience company employees, and university students and researchers with advanced registration. All others may purchase tickets.
Registration: Click here to register.
Sponsors: Hosted by Virginia Biotechnology Research Park and Sponsored by PhRMA.

Event: Virginia Bio Commercialization Luncheon - March 2016
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, March 10, 11:30am - 1:30pm
Details: Coming soon.
Sponsors: Greater Richmond Partnership, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

Virginia Bio, was formed in 1992 and incorporated in the Commonwealth of Virginia as a non-profit association. The purpose of the Association is to promote the biotechnology industry in Virginia, expand the knowledge and expertise of Virginia's businesses concerning biotechnology through seminars, educational publications and other means, to enhance public awareness of the biotechnology industry in Virginia and the scientific, economic and other benefits it provides, and to represent the interests of the biotechnology industry in Virginia before federal, state and local legislators and regulators.  We provide a forum for members and their guests to get to know each other and the many bioscience companies operating today in Virginia and serving our biotech community. We coordinate information among the many agencies and organizations interested in biotechnology.

To learn more about Virginia Bio and how you can get involved, Click Here

This is the E-newsletter of Virginia Bio, a non-profit organization dedicated to supporting the Life Sciences community in the Commonwealth of Virginia. New subscribers can join at our website,  
This email was sent to '@@email@@' from Virginia Bio. If you wish to stop receiving email from us, you can simply remove yourself by clicking here.
 In order to continue receiving emails from Virginia Bio, please add to your safe sender list.

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected